LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | AZD-6482 | 10 | uM | LJP5 | 72 | hr | 1209 | 1478 | 4203 | 0.3503 | 0.1121 |
MCF7 | NU7441 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4014 | 4203 | 0.9547 | 0.9482 |
MCF7 | NU7441 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3929 | 4203 | 0.9360 | 0.9282 |
MCF7 | NU7441 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3777 | 4203 | 0.8990 | 0.8849 |
MCF7 | NU7441 | 1.11 | uM | LJP5 | 72 | hr | 1209 | 3487 | 4203 | 0.8305 | 0.8038 |
MCF7 | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 3054 | 4203 | 0.7274 | 0.6752 |
MCF7 | NU7441 | 10 | uM | LJP5 | 72 | hr | 1209 | 1259 | 4203 | 0.2999 | 0.0219 |
MCF7 | Barasertib | 10 | uM | LJP5 | 72 | hr | 1209 | 1468 | 4203 | 0.3504 | 0.1148 |
MCF7 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 3350 | 4203 | 0.7974 | 0.7628 |
MCF7 | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4347 | 4203 | 1.0360 | 1.0407 |
MCF7 | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 4259 | 4203 | 1.0147 | 1.0170 |
MCF7 | Vemurafenib | 10 | uM | LJP5 | 72 | hr | 1209 | 3596 | 4203 | 0.8555 | 0.8330 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4156 | 4203 | 0.9898 | 0.9893 |
MCF7 | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 1209 | 3959 | 4203 | 0.9436 | 0.9368 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3621 | 4203 | 0.8617 | 0.8409 |
MCF7 | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 1209 | 2911 | 4203 | 0.6935 | 0.6314 |
MCF7 | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3523 | 4203 | 0.8394 | 0.8147 |
MCF7 | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 997 | 4203 | 0.2378 | -0.1018 |
MCF7 | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3073 | 4203 | 0.7306 | 0.6782 |
MCF7 | Barasertib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 1502 | 4203 | 0.3579 | 0.1279 |
MCF7 | Barasertib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 1458 | 4203 | 0.3476 | 0.1101 |
MCF7 | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1454 | 4203 | 0.3463 | 0.1077 |
MCF7 | Barasertib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 1417 | 4203 | 0.3379 | 0.0926 |
MCF7 | Pelitinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1741 | 4203 | 0.4143 | 0.2239 |
MCF7 | Pelitinib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 2812 | 4203 | 0.6699 | 0.6000 |